Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians

BACKGROUND: In women with early breast cancer, a pathological complete response (pCR) after neoadjuvant chemotherapy is reported to be associated with an improvement of the survival. The aim of this survey among physicians was to investigate whether the probability of achieving pCR in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Gass, Paul, Untch, Michael, Müller, Volkmar, Möbus, Volker, Thomssen, Christoph, Häberle, Lothar, Erber, Ramona, Hein, Alexander, Jud, Sebastian Michael, Lux, Michael P., Hack, Carolin C., Hartmann, Arndt, Kolberg, Hans-Christian, Ettl, Johannes, Lüftner, Diana, Jackisch, Christian, Beckmann, Matthias W., Janni, Wolfgang, Schneeweiss, Andreas, Fasching, Peter A., Nabieva, Naiba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059863/
https://www.ncbi.nlm.nih.gov/pubmed/30057427
http://dx.doi.org/10.1055/a-0642-9462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059863/
https://www.ncbi.nlm.nih.gov/pubmed/30057427
http://dx.doi.org/10.1055/a-0642-9462

Ejemplares similares